Sarepta Therapeutics, Inc.SRPTNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+33.1%
5Y CAGR+32.4%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+33.1%/yr
vs +32.7%/yr prior
5Y CAGR
+32.4%/yr
Consistent
Acceleration
+0.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.1x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$2.20B+15.6%
2024$1.90B+53.0%
2023$1.24B+33.3%
2022$933.01M+32.9%
2021$701.89M+30.0%
2020$540.10M+41.8%
2019$380.83M+26.5%
2018$301.03M+94.7%
2017$154.58M+2751.6%
2016$5.42M-